期刊文献+

结肠腺癌组织中Nup358的表达及意义

暂未订购
导出
摘要 目的观察结肠腺癌组织中的核孔素358(Nup358)表达变化,探讨其表达与结肠腺癌临床病理特征之间的关系。方法结肠腺癌患者80例,行左半结肠切除术或右半结肠切除术,术中留取肿瘤组织、癌旁组织(距肿瘤组织5 cm以上的结肠组织)。采用免疫组化Envision染色法检测80例结肠腺癌组织及相应癌旁组织中的Nup358。结果 80例标本中,结肠腺癌组织中Nup358表达阳性56例(70.00%),癌旁组织中表达阳性10例(12.50%),两者相比,P<0.01。结肠腺癌组织中Nup358的表达与结肠癌浸润深度无关(P>0.05),与肿瘤分化程度及淋巴结转移相关,Nup358在低分化者中表达低于高中分化者,在有淋巴结转移者中表达高于无淋巴结转移者(P均<0.05)。结论结肠腺癌组织中Nup358的表达上调,并与结肠腺癌分化程度及淋巴结转移有关。
出处 《山东医药》 CAS 2012年第10期73-75,共3页 Shandong Medical Journal
  • 相关文献

参考文献27

  • 1Wu J,Matunis MJ,Kraemer D. Nup358,a cytoplasmically exposed nucleoporin with peptide repeats,Ran-GTP binding sites,zinc fingers,a cyclophilin a homologous domain,and a leucine-rich region[J].Journal of Biological Chemistry,1995,(23):14209-14213.
  • 2Hutten S,Wilde S,Spillner C. The nuclear pore component Nup358 promotes transportin-dependent nuclear import[J].Journal of Cell Science,2009,(08):1100-1110.doi:10.1242/jcs.040154.
  • 3Salina D,Enarson P,Rattner JB. Nup358 integrates nuclear envelope breakdown with kinetochore assembly[J].Journal of Cell Biology,.
  • 4Hamada M,Haeger A,Jeganathan KB. Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell visbility[J].Journal of Cell Biology,2011,(04):597-612.doi:10.1083/jcb.201102018.
  • 5Murawala P,Tripathi MM,Vyas P. Nup358 interacts with APC and plays a role in cell polarization[J].Journal of Cell Science,2009,(Pt17):3113-3122.
  • 6Joseph J,Liu ST,Jablonski SA. The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo[J].Current Biology,2004,(07):611-617.doi:10.1016/j.cub.2004.03.031.
  • 7Joseph J,Dasso M. The nucleoporin Nup358 associates with and regulates interphase microtubules[J].FEBS Letters,2008,(02):190-196.doi:10.1016/j.febslet.2007.11.087.
  • 8Rusan NM,Peifer M. Orignal CIN:reviewing roles for APC in chromosome instability[J].Journal of Cell Biology,2008,(05):719-726.doi:10.1083/jcb.200802107.
  • 9Funasaka T,Wong RW. The role of nuclear pore complex in tumor microenvironment and metastasis[J].Cancer and Metastasis Review,2011,(02):239-251.
  • 10Phelps RA,Broadbent TJ,Stafforini DM. New perspectives on APC control of cell fate and proliferation in colorectal cancer[J].Cell Cycle,2009,(16):2549-2556.doi:10.4161/cc.8.16.9278.

二级参考文献53

  • 1雷彩霞,张炜,孙晓炜,杜国平,王丽,刘银坤.Galectin-3表达抑制对子宫内膜上皮细胞生长周期和黏附性的影响[J].复旦学报(医学版),2007,34(2):169-175. 被引量:12
  • 2程变巧,姜泊,包杰.Galectin-3 shRNA载体的构建表达及其对大肠癌细胞lovo增殖率的影响[J].第四军医大学学报,2007,28(11):1014-1017. 被引量:3
  • 3HSU C G, LIN L Y, KO J L, et al. High expression of human nonmetastatic clone 23 type 1 in cancer of uterine cervix and its association with poor cell differentiation and worse overall survival[J]. JSurg Oncol, 2008, 98(6): 448-456.
  • 4YANG R Y, HSU D K, LIU F T. Expression of galectin-3 modulates T-cell growth and apoptosis[J]. Proc Nat/AcadSci USA, 1996, 93(13): 6737-6742.
  • 5NANGIA-MAKKER P, HONJO Y, SARVIS R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis[J]. Am J Pathol, 2000, 156(3): 899-909.
  • 6SHEKHAR M P, NANGIA-MAKKER P, TAIT L, et al. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions[J]. Am JPathol, 2004, 165(6): 1931-1941.
  • 7MATARRESE P, FUSCO Galectin-3 ove apoptosis by rexpres O, TINARI N, et al. sion protects from mproving cell adhesion properties[J]. Int J Cancer, 2000, 85(4)545-554.
  • 8FUKUMORI T, KANAYAMA H O, RAZ A. The role of galectin-3 in cancer drug resistance[J]. Drug Resist Updat, 2007, 10(3): 101 -108.
  • 9CANESIN G, GONZALEZ-PERAMATO P, PALOU J, et al. Galectin-3 expression is associated with bladder cancer progression and clinical outcome[J]. Tumour Biol, 2010, 31 (4): 277-285.
  • 10SAKAKI M, FUKUMORI T, FUKAWA T, et al Clinical significance of Galectin-3 in clear cel renal cell carcinoma[J].J Med Invest, 2010 57(1/2): 152-157.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部